{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:33:44Z","timestamp":1791200024760,"version":"4.2.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1067\/mjd.2002.120468","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T22:14:26Z","timestamp":1030227266000},"page":"40-46","source":"Crossref","is-referenced-by-count":67,"title":["Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS"],"prefix":"10.1067","volume":"47","author":[{"given":"Muriel","family":"Eliaszewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Flahault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Fillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Challine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Mansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9lim","family":"Aractingi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Penso-Assathiany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Maslo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bourgault-Villada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Caumes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2002.120468_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199306103282304","article-title":"Cutaneous disease and drug reactions in HIV infection","volume":"328","author":"Coopman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2002.120468_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199506000-00007","article-title":"Two-day oral desensibilization to trimethoprim-sulphamethoxazole in HIV-infected patients","volume":"9","author":"Nguyen","year":"1995","journal-title":"AIDS"},{"key":"10.1067\/mjd.2002.120468_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/BF02599836","article-title":"Predicting cutaneous hypersensitivity reactions to cotrimoxazole in HIV-infected individuals receiving primary Pneumocystis carinii pneumonia prophylaxis","volume":"10","author":"Hennesy","year":"1995","journal-title":"J Gen Intern Med"},{"key":"10.1067\/mjd.2002.120468_bib4","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/00002030-199311000-00023","article-title":"Patterns of multiple-drug hypersensitivities in HIV-infected patients","volume":"7","author":"Carr","year":"1993","journal-title":"AIDS"},{"key":"10.1067\/mjd.2002.120468_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/infdis\/168.2.314","article-title":"Crossover of human immunodeficiency virus-infected patients from aerosolized pentamidine to trimethoprim-sulfamethoxazole: lack of hematologic toxicity and relationship of side effects to CD4+ lymphocyte count","volume":"168","author":"Kennedy","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1067\/mjd.2002.120468_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/clinids\/24.5.936","article-title":"Rapid disease progression in human immunodeficiency virus type 1-infected individuals with adverse reactions to trimethoprim-sulfamethoxazole prophylaxis","volume":"24","author":"Veenstra","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1067\/mjd.2002.120468_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2230.1997.tb01038.x","article-title":"Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease","volume":"22","author":"Smith","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"10.1067\/mjd.2002.120468_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/infdis\/167.1.180","article-title":"Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS","volume":"167","author":"Carr","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1067\/mjd.2002.120468_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00002030-199403000-00006","article-title":"Acetylation phenotype and cutaneous hypersensitivity to trimethoprim-sulfamethoxazole in HIV-infected patients","volume":"8","author":"Carr","year":"1994","journal-title":"AIDS"},{"key":"10.1067\/mjd.2002.120468_bib10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/S0140-6736(89)91909-0","article-title":"Systemic glutathione deficiency in symptom-free HIV seropositive individuals","volume":"334","author":"Buhl","year":"1989","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120468_bib11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-116-1-33","article-title":"Treatment of toxoplasmic encephalitis in patients with AIDS","volume":"116","author":"Dannemann","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2002.120468_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/clinids\/18.3.319","article-title":"Effects of corticosteroids on the incidence of adverse reactions to trimethoprim-sulfamethoxazole during treatment of AIDS-associated Pneumocystis carinii pneumonia","volume":"18","author":"Caumes","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1067\/mjd.2002.120468_bib13","first-page":"348","article-title":"A multicenter randomized double-blind placebo controlled trial of adjunctive corticosteroids in the treatment of Pneumocystis carinii pneumonia complicating the acquired immune deficiency syndrome","volume":"8","author":"Walmsley","year":"1995","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/mjd.2002.120468_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/archderm.1994.01690050095017","article-title":"Drug rashes. What are the targets of cell-mediated cytotoxicity?","volume":"130","author":"Chosidow","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120468_bib15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/00008571-200012000-00007","article-title":"Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulfonamides in AIDS","volume":"10","author":"Wolkenstein","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1067\/mjd.2002.120468_bib16","first-page":"33","article-title":"Detection and variant identification of HHV 6 by a non radioactive hybridization microplate assay for amplimers detection","volume":"58","author":"Gautheret","year":"1996","journal-title":"J Virol Med"},{"key":"10.1067\/mjd.2002.120468_bib17","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1128\/JCM.32.10.2434-2440.1994","article-title":"Identification of human herpesvirus 6 variants A and B by amplimer hybridization with variant-specific oligonucleotides and amplification with variant-specific primers","volume":"32","author":"Aubin","year":"1994","journal-title":"J Clin Microbiol"},{"key":"10.1067\/mjd.2002.120468_bib18","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(96)07560-5","article-title":"Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen","volume":"348","author":"Simpson","year":"1996","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120468_bib19","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1086\/517080","article-title":"Cutaneous adverse reactions and CD4+ cell counts in human immunodeficiency virus infected patients receiving trimethoprime-sulfamethoxazole","volume":"26","author":"Caumes","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1067\/mjd.2002.120468_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0140-6736(91)91046-W","article-title":"Adverse reactions to co-trimoxazole in HIV infection","volume":"338","author":"Van der Ven","year":"1991","journal-title":"Lancet"},{"key":"10.1067\/mjd.2002.120468_bib21","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/00002030-199605000-00008","article-title":"Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency","volume":"10","author":"Pirmohamed","year":"1996","journal-title":"AIDS"},{"key":"10.1067\/mjd.2002.120468_bib22","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0163-4453(97)91578-4","article-title":"N-acetylcystein treatment and the risk of toxic reactions to trimethoprim-sulfamethoxazole in primary Pneumocystis carinii prophylaxis in HIV-infected patients","volume":"35","author":"Akerlund","year":"1997","journal-title":"J Infect"},{"key":"10.1067\/mjd.2002.120468_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/clpt.1993.66","article-title":"Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome","volume":"53","author":"Lee","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1067\/mjd.2002.120468_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2125.1994.tb04401.x","article-title":"Acetylation genotype and risk of severe reactions to sulfonamides in AIDS patients","volume":"38","author":"Delom\u00e9nie","year":"1994","journal-title":"Br J Clin Pharmacol"},{"key":"10.1067\/mjd.2002.120468_bib25","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/00002030-200002180-00021","article-title":"Efavirenz associated with corticosteroids in patients with previous severe hypersensitivity reaction due to nevirapine","volume":"14","author":"Podzamzer","year":"2000","journal-title":"AIDS"},{"key":"10.1067\/mjd.2002.120468_bib26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1093\/clinids\/21.3.656","article-title":"Adverse cutaneous reactions to pyrimethamine\/sulfadiazine and pyrimethamine\/clindamycin in patients with AIDS and toxoplasmic encephalitis","volume":"21","author":"Caumes","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1067\/mjd.2002.120468_bib27","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archderm.135.3.350","article-title":"High-dose trimethoprim-sulfamethoxazole therapy with corticosteroids in previously-intolerant patients with AIDS-associated Pneumocystis carinii pneumonia","volume":"135","author":"Iborra","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2002.120468_bib28","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/00002030-199911120-00016","article-title":"Prednisolone does not prevent the occurrence of nevirapine-induced rashes","volume":"13","author":"Rey","year":"1999","journal-title":"AIDS"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202000154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962202000154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T13:03:24Z","timestamp":1583413404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962202000154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0190962202000154"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2002.120468","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}